chr2-47414421-A-G

Variant summary

Our verdict is . The variant received 6 ACMG points: 6P and 0B. PS3PP3PP5

The NM_000251.3(MSH2):​c.942+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000565825: Published functional studies demonstrate a damaging effect: RNA studies demonstrate abnormal splicing (PMID:31642931)" and additional evidence is available in ClinVar. The gene MSH2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00034 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MSH2
NM_000251.3 splice_region, intron

Scores

3
Splicing: ADA: 0.9973
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:6U:2

Conservation

PhyloP100: 2.32

Publications

97 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Muir-Torre syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000251.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000565825: Published functional studies demonstrate a damaging effect: RNA studies demonstrate abnormal splicing (PMID: 31642931); SCV001134379: Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant may affect proper MSH2 mRNA splicing. PMID: 31642931 (2019); SCV001180678: RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data).; SCV004100206: At least one publication reports experimental evidence that this variant affects mRNA splicing and re-classified this variant from VUS to likely pathogenic (example: Karam_2019). PMID: 31642931
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant 2-47414421-A-G is Pathogenic according to our data. Variant chr2-47414421-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 418625.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.942+3A>G
splice_region intron
N/ANP_000242.1P43246-1
MSH2
NM_001406674.1
c.942+3A>G
splice_region intron
N/ANP_001393603.1
MSH2
NM_001406631.1
c.942+3A>G
splice_region intron
N/ANP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.942+3A>G
splice_region intron
N/AENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.942+3A>G
splice_region intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.993+3A>G
splice_region intron
N/AENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
2862
Hom.:
0
Cov.:
0
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000344
AC:
3
AN:
8720
Hom.:
0
Cov.:
0
AF XY:
0.000461
AC XY:
2
AN XY:
4338
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
296
American (AMR)
AF:
0.00
AC:
0
AN:
680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
262
East Asian (EAS)
AF:
0.00
AC:
0
AN:
68
South Asian (SAS)
AF:
0.00
AC:
0
AN:
582
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
36
European-Non Finnish (NFE)
AF:
0.000321
AC:
2
AN:
6226
Other (OTH)
AF:
0.00238
AC:
1
AN:
420
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
2862
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
1490
African (AFR)
AF:
0.00
AC:
0
AN:
1344
American (AMR)
AF:
0.00
AC:
0
AN:
100
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20
East Asian (EAS)
AF:
0.00
AC:
0
AN:
14
South Asian (SAS)
AF:
0.00
AC:
0
AN:
26
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
512
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
818
Other (OTH)
AF:
0.00
AC:
0
AN:
24
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
1
-
Hereditary cancer-predisposing syndrome (2)
2
-
-
not provided (2)
1
-
-
Hereditary nonpolyposis colon cancer (1)
1
-
-
Hereditary nonpolyposis colorectal neoplasms (1)
1
-
-
Lynch syndrome 1 (1)
-
1
-
Muir-Torré syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
21
DANN
Benign
0.95
PhyloP100
2.3

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.80
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.